论文部分内容阅读
目的:探究血浆超敏C-反应蛋白对糖尿病合并冠心痛的预测价值。方法:选取2012年6月至2014年10月间入住我院的糖尿病患者50例作为实验组,其中A组为仅患糖尿病患者32例,B组为糖尿病合并冠心痛18例,另外选取50例健康者作为对照组C组。分别对三组进行血浆超敏C-反应蛋白、总胆固醇、低密度脂蛋白胆固醇等进行检测分析。结果:A组血浆超敏C-反应蛋白水平较C组有差异,B组血浆超敏C-反应蛋白水平较C组有明显差异。结论:血浆超敏C-反应蛋白水平对糖尿病可能有致病作用,而对于糖尿病合并冠心痛更具有临床意义,因此对其的研究分析具有临床可推广性。
Objective: To investigate the predictive value of plasma hypersensitive C-reactive protein in diabetic patients with coronary heart disease. Methods: Fifty patients with diabetes mellitus admitted to our hospital from June 2012 to October 2014 were selected as the experimental group, including 32 patients with diabetes mellitus only in group A, 18 patients with diabetes mellitus and coronary heart disease in group B, and 50 patients Healthy people as a control group C group. The three groups were tested for plasma hypersensitivity C-reactive protein, total cholesterol and low-density lipoprotein cholesterol. Results: The level of plasma hypersensitive C-reactive protein in group A was significantly different from that in group C, while the level of plasma hypersensitive C-reactive protein in group B was significantly different from that in group C. CONCLUSION: Plasma Hypersensitive C-reactive protein level may have pathological effects on diabetes mellitus, but it is more clinically significant for diabetic patients with coronary heart disease. Therefore, its research and analysis have clinical feasibility.